Pre-therapy KcL models (in which G12C is conditionally mutated and which are LKB1-deficient) uniformly display adenocarcinoma histology: resistance develops upon G12C inhibition again through squamous differentiation and despite maintained repression of RAS signalling45. The gene discussed is STK11; the disease is adenocarcinoma.